AstraZeneca will present new data in liver, biliary tract and prostate cancers illustrating its ambition to revolutionize cancer care at the 2022 American Society of Clinical Oncology Gastrointestinal ...

Patients with cardiovascular disease who develop major internal bleeding are much more likely to be diagnosed with cancer, a large international clinical trial has found. Patients with ...

Data on the benefit of the use of IMRT are critically important if we are to understand the dosimetric and clinical tradeoffs of IMRT over conventional techniques and to design future technical and ...

Patients with atherosclerosis on antithrombotic drugs who report gastrointestinal or genitourinary bleeding are at a substantially higher risk for new cancer diagnoses in those organ systems compared ...